Image Credit: STAT News
Versant enters obesity with new startup
Versant Ventures is joining the obesity race, launching a startup called Pep2Tango Therapeutics. Pep2Tango is developing drugs to target GLP-1 and GIP receptors — the same ones hit by Eli…